Researchers and drug makers are interested in studying coadministration and associated safety and efficacy, or giving multiple vaccines to a person during one visit, to ease logistics and help ...

No new safety concerns were observed with coadministration. “These new safety and immunogenicity data provide further evidence supporting the potential to administer Prevnar 20 and the Pfizer ...

The initiation of the study exploring the coadministration of PREVNAR 20 along with a booster dose of the Pfizer-BioNTech COVID-19 Vaccine in older adults was announced in May 2021. The study ...

The Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) this week recommended new contraindications on the coadministration of the protease inhibitor ...

Findings showed a noninferior immune response for both vaccines when coadministered compared with separate administration. Topline results were announced from a phase 3 study assessing the immune ...

(RTTNews) - Drug major Pfizer Inc. (PFE) announced Wednesday positive top-line results from a Phase 3 study (B7471004) exploring coadministration of Prevnar 20 with seasonal flu vaccine in older ...

The primary endpoint of the study was percentage of change in LDL cholesterol with coadministration of ezetimibe-simvastatin plus fenofibrate vs fenofibrate. Patients and Treatment After a placebo ...

Coadministration of CD19- and CD22-chimeric antigen receptor T-cell therapy may be a promising therapeutic strategy for patients with relapsed or refractory B-acute lymphoblastic leukemia. However, ...

Patients also taking beta blockers, or those with underlying cardiac comorbidities and/or advanced liver disease may be at increased risk for symptomatic bradycardia with coadministration of ...

The article by Wang et al entitled “Coadministration of CD19- and CD22-Directed Chimeric Antigen Receptor T-Cell Therapy in Childhood B-Cell Acute Lymphoblastic Leukemia: A Single-Arm, Multicenter, ...